Cancerbackup: Maintenance treatment

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234



Skip the main content if you do not want to read it as the next section.


Maintenance treatment for myeloma

Maintenance treatment may be used to try to keep people with myeloma in remission for as long as possible. The drugs which may be used are interferon, steroids and thalidomide. Research is looking at maintenance treatment for myeloma.

New drugs such as bortezomib and lenalidomide are also being looked at to see if they help keep people in remission.


Interferon 

This is a protein that is normally produced by the body during viral infections, such as flu. It is given as a cancer treatment to stimulate a person's immune system to attack the myeloma cells. Interferon may be used as a maintenance treatment, to try to keep the myeloma in remission after chemotherapy. It can help to control the disease, but sometimes the side effects can outweigh the benefits.

Interferon is given three times a week, or occasionally daily, as a small injection under the skin (subcutaneously) using a very fine needle. The injections are slightly uncomfortable. You will be taught how to give yourself these injections.

In the first week or two of treatment, interferon can cause symptoms similar to those of flu; especially chills, a high temperature, headache, and aching in the back, joints and muscles. Your doctor may recommend that you take paracetamol, about half an hour before the injection, to prevent these symptoms.

The side effects often disappear within a few weeks of starting treatment, but for some people they continue. Interferon can also make you feel very tired.


Content last reviewed: 01 November 2007
Page last modified: 14 February 2008

Get support

Look for other people in the same situation on our What Now? community - read their blogs or talk to them in our chat rooms.

Find out about other ways to get support on the main Macmillan website.